Pharmaceuticals

Personalized Genomics Industry Growth Insights: Revenue Forecast to 2030

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the personalized genomics market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Personalized Genomics Market in 2030?

The personalized genomics market has seen rapid expansion in recent years. Its value is expected to rise from $9.45 billion in 2025 to $10.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.0%. This historical growth can be attributed to several factors including the declining costs of genetic sequencing, an increasing prevalence of chronic and genetic diseases, a rise in research-based genomics studies, the expansion of diagnostic laboratory infrastructure, and the early adoption of precision medicine approaches.

The personalized genomics market is poised for substantial expansion in the coming years, with its size projected to reach $19.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.7%. This growth over the forecast period is fueled by several factors, including the integration of genomics into standard clinical practice, a surging demand for personalized medicine, continuous advancements in sequencing technologies, the broadening availability of wellness and ancestry testing, and increasing investments from pharmaceutical and biotechnology companies. Significant trends anticipated during this period include the rising adoption of direct-to-consumer genetic testing, the expanding application of pharmacogenomics in treatment planning, a greater emphasis on preventive and predictive healthcare, the wider use of genetic testing in reproductive health, and enhanced consumer awareness regarding lifestyle and wellness genomics.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

What Drivers Are Influencing Production Trends In The Personalized Genomics Market?

The increasing occurrence of chronic illnesses is anticipated to boost the personalized genomics market in the future. These are enduring health conditions, such as diabetes, heart disease, and high blood pressure, among other intricate health problems, necessitating continuous care. The rise in such diseases is primarily linked to an aging global population, inactive lifestyles, inadequate nutrition, and environmental elements, which together foster the simultaneous emergence of several health conditions. Personalized genomics assists in managing chronic diseases by facilitating extensive genotyping and sequencing, which helps categorize patients based on their genetic risk, leading to more accurate diagnoses, focused treatments, and improved preventive measures. For example, data from April 2025 provided by the U.S. Centers for Disease Control and Prevention (CDC), an organization based in the US, indicated that 76.4% of American adults, roughly 194 million individuals, were affected by at least one of 12 specific chronic conditions, while 51.4% (approximately 130 million) suffered from two or more of these conditions. Consequently, the growing frequency of chronic diseases is fueling the expansion of the personalized genomics market.

Which Segments Are Gaining Traction In The Personalized Genomics Market?

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

3) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Coronary Artery Disease Testing

4) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Ancestry Testing

What Industry Trends Are Transforming The Personalized Genomics Market?

Leading companies operating in the personalized genomics market are concentrating on developing advanced technologies, such as personalized genomics platforms, to offer customized insights into well-being, health, and disease prevention. A personalized genomics platform is a system designed to analyze an individual’s genetic data, thereby providing tailored insights and recommendations concerning health, wellness, and the likelihood of disease. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostic service company, introduced Geniee Decode Your DNA, which is a new customized genomics platform. This platform delivers personalized insights on health, nutrition, and medication based on an individual’s genetic profile, helping to optimize wellness, prevent diseases, and tailor treatments for improved health outcomes.

Who Are The Top-Performing Companies In The Personalized Genomics Market In Recent Years?

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

Which Region Currently Holds The Largest Share Of The Personalized Genomics Market?

North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Personalized Genomics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24654&type=smp

Browse Through More Reports Similar to the Global Personalized Genomics Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Pharmacogenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Genomics In Cancer Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795